Evidence map›Paper›PMID 20222015›Full record

ReviewIUBMB life2010

Mammalian ceramide synthases.

Michal Levy, Anthony H Futerman

Open access · bronzeAbstract readReview
In one paragraph

Review in IUBMB life, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 351 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
351citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

351 citing papers in PubMed, 1 synthesis or guideline pooled it, 620 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Determinants of CBiomolecules · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Localization of Ceramide Synthase 5 in Mouse Retina.The Journal of comparative neurology · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Selective Editing and Functionalization of the Mammalian Lipidome.bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

291 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michal LevyDepartment of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Anthony H Futerman
Weizmann Institute of Science · IL

Funding

Characterization of Mammalian Ceramide SynthasesR01GM076217 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI MERRILL, ALFRED HARRISON · 2007 to 2015
$2.4M
NIGMS NIH HHS GM076217NIGMS NIH HHS R01 GM076217
6 · The paper itself

Abstract

In mammals, ceramide, a key intermediate in sphingolipid metabolism and an important signaling molecule, is synthesized by a family of six ceramide synthases (CerS), each of which synthesizes ceramides with distinct acyl chain lengths. There are a number of common biochemical features between the CerS, such as their catalytic mechanism, and their structure and intracellular localization. Different CerS also display remarkable differences in their biological properties, with each of them playing distinct roles in processes as diverse as cancer and tumor suppression, in the response to chemotherapeutic drugs, in apoptosis, and in neurodegenerative diseases.

Indexed as

AnimalsGene Expression Regulation, EnzymologicHumansMembrane ProteinsNeoplasmsSphingosineSphingosine N-AcyltransferaseTumor Suppressor ProteinsCERS1 protein, humanCERS2 protein, humanCerS3 protein, mouseCERS5 protein, humanCERS6 protein, humanMembrane ProteinssafingolSphingosineSphingosine N-AcyltransferaseTumor Suppressor Proteins

Identifiers

PMID20222015
PMCPMC2858252
OpenAlexW1989832969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.